SNSE Insider Trading Activity and SEC Form 4 Filings
SNSE insider trading summary
Over the past 12 months, insiders at Sensei Biotherapeutics, Inc. (SNSE) reported 116 sales worth $3.4M by 6 insiders and 104 open-market purchases worth $5.4M by 4 insiders on SEC Form 4. Net insider buying was $2.0M.
Latest SNSE insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 7, 2026 | Ics Opportunities II LLC | 10% Owner | Sell | $61K (2,115 @ $28.94) |
| Apr 7, 2026 | Millennium Management LLC | 10% Owner | Sell | $6K (205 @ $29.71) |
| Apr 7, 2026 | Millennium Group Management LLC | 10% Owner | Buy | $37K (1,108 @ $33.38) |
| Apr 7, 2026 | Millennium Management LLC | 10% Owner | Sell | $61K (2,115 @ $28.94) |
| Apr 7, 2026 | Millennium Group Management LLC | 10% Owner | Sell | $61K (2,115 @ $28.94) |
| Apr 7, 2026 | Israel A Englander | 10% Owner | Sell | $61K (2,115 @ $28.94) |
| Apr 7, 2026 | Millennium Management LLC | 10% Owner | Buy | $37K (1,108 @ $33.38) |
| Apr 7, 2026 | Ics Opportunities II LLC | 10% Owner | Buy | $37K (1,108 @ $33.38) |
| Apr 7, 2026 | Israel A Englander | 10% Owner | Buy | $37K (1,108 @ $33.38) |
| Apr 7, 2026 | Ics Opportunities II LLC | 10% Owner | Sell | $6K (205 @ $29.71) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.